Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.99B |
| 2 |
Eli Lilly
LLY
|
+$3.22B |
| 3 |
UnitedHealth
UNH
|
+$2.21B |
| 4 |
Amazon
AMZN
|
+$2.17B |
| 5 |
Applied Materials
AMAT
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$6.48B |
| 2 |
Boeing
BA
|
+$4.34B |
| 3 |
Royal Caribbean
RCL
|
+$2.21B |
| 4 |
Broadcom
AVGO
|
+$1.17B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 10.59% |
| 5 | Financials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Nutrien
NTR
$32.2B
| $67.1M | 0.01% |
1,143,265
+9,488
| +0.8% | +$553K |
|
327
Constellation Brands
STZ
$23.3B
| $66.8M | 0.01% |
496,340
-101,656
| -17% | -$16.2M |
|
328
Matsons
MATX
$6.39B
| $65.4M | 0.01% |
663,825
-75,066
| -10% | -$8.02M |
|
329
Deere & Co
DE
$165B
| $64.7M | 0.01% |
141,493
+1,158
| +0.8% | +$571K |
|
330
FirstCash
FCFS
$9.14B
| $63.7M | 0.01% |
402,112
+176,549
| +78% | +$24.7M |
|
331
Oshkosh
OSK
$9.41B
| $63.4M | 0.01% |
+489,134
| New | +$64.9M |
|
332
Floor & Decor
FND
$6.27B
| $62.6M | 0.01% |
850,023
-525,170
| -38% | -$43M |
|
333
Edison International
EIX
$27.2B
| $62.3M | 0.01% |
1,126,693
-3,197,652
| -74% | -$173M |
|
334
Berkshire Hathaway Class A
BRK.A
$1.09T
| $61.8M | 0.01% |
82
| – | – |
|
335
Western Union
WU
$2.34B
| $61.5M | 0.01% |
7,691,575
+11,668
| +0.2% | +$97.6K |
|
336
nCino
NCNO
$2.26B
| $60.4M | 0.01% |
2,229,082
-597,837
| -21% | -$17.5M |
|
337
Rhythm Pharmaceuticals
RYTM
$7.99B
| $60.4M | 0.01% |
+598,247
| New | +$55.5M |
|
338
AstraZeneca
AZN
$244B
| $60.2M | 0.01% |
392,630
+4,153
| +1% | +$629K |
|
339
Tetra Tech
TTEK
$9.33B
| $59.7M | 0.01% |
1,787,103
| – | – |
|
340
Regeneron Pharmaceuticals
REGN
$83B
| $59.5M | 0.01% |
105,749
+3,635
| +4% | +$2.06M |
|
341
Camping World
CWH
$675M
| $58.7M | 0.01% |
3,715,646
+499,999
| +16% | +$8.56M |
|
342
Ollie's Bargain Outlet
OLLI
$4.7B
| $58.3M | 0.01% |
453,972
-250,138
| -36% | -$33.2M |
|
|
WCC
343
WESCO International
WCC
$17.5B
| $57.2M | 0.01% |
270,312
| – | – |
|
344
Shell
SHEL
$248B
| $55.3M | 0.01% |
773,610
+1,306
| +0.2% | +$94K |
|
345
Welltower
WELL
$169B
| $54.6M | 0.01% |
306,310
| – | – |
|
|
UMH
346
UMH Properties
UMH
$1.42B
| $54.5M | 0.01% |
3,671,303
-1,800,000
| -33% | -$28.8M |
|
347
StepStone Group
STEP
$4.28B
| $51.9M | 0.01% |
794,883
| – | – |
|
348
CONMED
CNMD
$1.49B
| $48.6M | 0.01% |
1,032,733
-643,431
| -38% | -$33.4M |
|
|
FISV
349
Fiserv Inc
FISV
$29.5B
| $48M | 0.01% |
372,056
+2,908
| +0.8% | +$417K |
|
350
MKS Inc
MKSI
$20.7B
| $47.9M | 0.01% |
387,153
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital Research Global Investors held 458 positions worth $533B, up 6.7% from $499B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Research Global Investors's Q3 2025 filing shows 30 new, 198 increased, 163 reduced and 25 closed positions. Its largest new stake was Corning: 11,058,929 shares worth $907M. The largest sale was Meta Platforms (Facebook), an estimated $6.48B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Capital Research Global Investors's largest Q3 2025 buy was Corning: 11,058,929 shares worth $907M.
- Capital Research Global Investors added most to NVIDIA in Q3 2025, an estimated $3.99B increase.
- Capital Research Global Investors's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.48B.
- Capital Research Global Investors fully exited Ansys in Q3 2025, selling an estimated $984M.
- Capital Research Global Investors's ten largest holdings make up 38% of its $533B portfolio in Q3 2025.
- Capital Research Global Investors opened 30 new positions and closed 25 in Q3 2025.
- Capital Research Global Investors's portfolio value rose 6.7% quarter-over-quarter to $533B.
Based on Capital Research Global Investors's 13F filing for Q3 2025, filed 13 Nov 2025.